(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.35%) $0.935
(0.55%) $11.01
(0.15%) $0.800
(0.00%) $92.17
Live Chart Being Loaded With Signals
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally...
Stats | |
---|---|
本日の出来高 | 6 653.00 |
平均出来高 | 26 736.00 |
時価総額 | 8.71M |
EPS | $0 ( 2024-01-02 ) |
次の収益日 | ( $0 ) 2024-06-19 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.65 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2014-01-31 | Doroudian Ahmad | Sell | 0 | Common Shares |
2014-01-31 | Doroudian Ahmad | Buy | 0 | Common Shares |
2011-01-31 | Doroudian Ahmad | Sell | 0 | Common Shares |
2011-01-31 | Doroudian Ahmad | Buy | 0 | Common Shares |
2010-05-25 | Doroudian Ahmad | Buy | 800 000 | Stock Options |
INSIDER POWER |
---|
0.00 |
Last 6 transactions |
Buy: 1 300 000 | Sell: 0 |
BetterLife Pharma Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
BetterLife Pharma Inc. 財務諸表
Annual | 2023 |
収益: | $0 |
総利益: | $-18 435.00 (0.00 %) |
EPS: | $-0.100 |
FY | 2023 |
収益: | $0 |
総利益: | $-18 435.00 (0.00 %) |
EPS: | $-0.100 |
FY | 2022 |
収益: | $26.93B |
総利益: | $26.93B (100.00 %) |
EPS: | $-0.160 |
FY | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-1.340 |
Financial Reports:
No articles found.
BetterLife Pharma Inc.
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's pipeline products include BETR-001 for the treatment of major depressive disorder, treatment resistance depression, cluster headaches, and post-traumatic stress disorder; and BETR-002 to treat benzodiazepine dependency, anxiety, and spasticity. It is also developing MM-003 for treatment of COVID-19 and other respiratory viral infections; MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and AP-002 for the treatment of cancer. BetterLife Pharma Inc. has a research agreement with the University of California San Diego for preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。